Insider Selling at Recursion Pharmaceuticals Inc.: CFO Sells 50,000 Shares
Recent SEC filings reveal that Michael Secora, Chief Financial Officer of Recursion Pharmaceuticals Inc (NASDAQ: RXRX), sold 50,000 shares of the company on March 13, 2024. On the valuation front, Recursion Pharmaceuticals Inc.'s shares were trading at $10.74 on the day of the recent insider sale, resulting in a market...